Lenita Hanson
Endocrinology, Diabetes & Metabolism · Port Charlotte, FLNPI 1225128572
Payments from drug & device makers
Across 1,275 payments — averaging $972.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$356K
- Eli Lilly$234K
- Boehringer Ingelheim International GmbH$179K
- Boehringer Ingelheim Pharma GmbH & Co.kg$140K
- Bayer$112K
- Sanofi US Services Inc.$74K
- plus $147K from 45 others
Across 28 payments — averaging $2246.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$37K
- Eli Lilly$23K
- Novo Nordisk AS$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,240,545 in reported general payments places this provider in the 95th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
See all endocrinology, diabetes & metabolism providers in Florida →
Other endocrinology, diabetes & metabolism in Port Charlotte
- Arelis MaderaPort Charlotte$1.7M
- Richard PratleyOrlando$9.2M
- Jose MandryOcoee$9.1M
- Steven SmithOrlando$7.9M
- Barry HorowitzWest Palm Beach$7.1M
- Tina ThethiOrlando$3.8M
- David SuttonJacksonville$3.1M
- Lorena Lewy-AlterbaumHollywood$3.1M
- Mae Sheikh AliJacksonville$2.9M
- James MageeJacksonville$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.